Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS20000082HPVENSG00000068078.20protein_codingFGFR3YesNo2261P22607
Q0IJ44
TVIS20007360HPVENSG00000068078.20protein_codingFGFR3YesNo2261P22607
Q0IJ44
TVIS20027601HPVENSG00000068078.20protein_codingFGFR3YesNo2261P22607
Q0IJ44
TVIS20027588HPVENSG00000068078.20protein_codingFGFR3YesNo2261P22607
Q0IJ44
TVIS20015105HPVENSG00000068078.20protein_codingFGFR3YesNo2261P22607
Q0IJ44
TVIS20019576HPVENSG00000068078.20protein_codingFGFR3YesNo2261P22607
Q0IJ44
TVIS20019577HPVENSG00000068078.20protein_codingFGFR3YesNo2261P22607
Q0IJ44
TVIS20030913HPVENSG00000068078.20protein_codingFGFR3YesNo2261P22607
Q0IJ44
TVIS44013030HTLV-1ENSG00000068078.20protein_codingFGFR3YesNo2261P22607
Q0IJ44
TCGA Plot Options
Drug Information
GeneFGFR3
DrugBank IDDB09078
Drug NameLenvatinib
Target IDBE0002133
UniProt IDP22607
Regulation Typeinhibitor
PubMed IDs17943726
CitationsMatsui J, Yamamoto Y, Funahashi Y, Tsuruoka A, Watanabe T, Wakabayashi T, Uenaka T, Asada M: E7080, a novel inhibitor that targets multiple kinases, has potent antitumor activities against stem cell factor producing human small cell lung cancer H146, based on angiogenesis inhibition. Int J Cancer. 2008 Feb 1;122(3):664-71.
GroupsApproved; Investigational
Direct ClassificationQuinoline carboxamides
SMILESCOC1=C(C=C2C(OC3=CC=C(NC(=O)NC4CC4)C(Cl)=C3)=CC=NC2=C1)C(N)=O
Pathways
PharmGKBPA166153472
ChEMBLCHEMBL1289601